Health & Bio

Moleculin MIRACLE AML Phase 2b/3 unblinding imminent; complete remission ~30%

Annamycin plus cytarabine in 45 R/R AML patients hits complete remission ~30% in blinded readout—exceeds historical benchmark. Results due before 6/30.

Primary sources · 2
GlobeNewswireBenzinga
← View the full 2026-05-15 (Fri) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →